Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYM-1219 for Bacterial Vaginosis
NCT02147899Phase 2Completed
- Sponsor
- Symbiomix Therapeutics
- Start
- May 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of secnidazole in bacterial vaginosis (BV), sponsored by Symbiomix Therapeutics. Started May 2014; status: completed.
02
Drugs
secnidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02147899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147899.